References
- European Glaucoma Society (EGS). Terminology and guidelines for glaucoma. 4th ed. Savona (Italy): PubliComm; 2014.
- Jonas JB, Aung T, Bourne R, et al. Glaucoma. Lancet. 2017;390(10108):2183–2193.
- Elbendary A, Helal R. Discriminating ability of spectral domain optical coherence tomography in different stages of glaucoma. Saudi J Ophthalmol. 2013;27:19–24.
- Tatham A, Mederos F. Detecting structural progression in glaucoma with optical coherence tomography. Ophtalmology. 2017;124(12):S57–S65.
- Soltani A, Battikh T, Jabri I, et al. A new expert system based on fuzzy logic and image processing algorithms for early glaucoma diagnosis. Biomed Signal Proc Control. 2018;40:366–377.
- Ban N, Siegfried C, Apte R. Monitoring neurodegeneration in glaucoma: therapeutic implications. Trends Mol Med. 2018;24(1):7–17.
- Wróbel-Dudzińska D, Kosior-Jarecka E, Łukasik U, et al. Risk factors in normal-tension glaucoma and high-tension glaucoma in relation to polymorphisms of endothelin-1 gene and endothelin-1 receptor type A gene. J Ophtalmol. 2015: 368792. DOI:10.1155/2015/368792
- Kosior-Jarecka E, Wróbel-Dudzińska D, Łukasik U, et al. Plasma endothelin-1 and single nucleotide polymorphisms of endothelin-1 and endothelin type A receptor genes as risk factors for normal tension glaucoma. Mol Vis. 2016;22:1256–1266.
- Flammer J, Konieczka K, Flammer AJ. The primary vascular dysregulation syndrome: implications for eye diseases. EPMA J. 2013:4(1):14. DOI 10.1186/1878-5085-4-14
- Mroczkowska S, Benavente-Perez A, Negi A, et al. Primary open-angle glaucoma vs normal-tension glaucoma: the vascular perspective. JAMA Ophthalmol. 2013;131(1):36–43.
- Houde M, Desbiens I, D’Orléans-Juste P. Endothelin-1: biosynthesis, signaling and vasoreactivity. Adv Pharmacol. 2016;77:143–175.
- Blanco R, Martínez-Navarrete G, Valiente-Soriano F, et al. The S1P1 receptor-selective agonist CYM-5442 protect retinal ganglion cells in endothelin-1 induced retinal ganglion cell loss. Exp Eye Res. 2017;164:37–45.
- Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332(6163):441–445.
- Mikhail M, Vachon P, D’Orléans-Juste P, et al. Role of endothelin-1 and its receptors ETA and ETB in the survival of human vascular endothelial cells. Can J Physiol Pharmacol. 2017;95(10):1298–1305.
- De Mey J, Vanhoutte P. End o' the line revisited: moving on from nitric oxide to CGRP. Life Sci. 2014;118:120–128.
- Chen H, Chang Y, Chen W, et al. Association between plasma endothelin-1 and severity of different types of glaucoma. J Glaucoma. 2013;22(2):117–122.
- López-Riquelme N, Villalba C, Tormo C, et al. Endothelin-1 levels and biomarkers of oxidative stress in glaucoma patients. Int Ophthalmol. 2015;35(4):527–532.
- McGrady N, Minton A, Stankowska D, et al. Upregulation of the endothelin A (ETA) receptor and its association with neurodegeneration in a rodent model of glaucoma. BMC Neurosci. 2017;18:27. DOI:10.1186/s12868-017-0346-3
- Ko A, Hyun H, Min S, et al. Endothelin-1 induces LIMK2-mediated programmed necrotic neuronal death independent of NOS activity. Mol Brain. 2015;8:58. DOI 10.1186/s13041-015-0149-3.
- He S, Park Y, Yorito T, et al. Endothelin-mediated changes in gene expression in isolated purified rat retinal ganglion cells. Invest Ophthalmol Vis Sci. 2015;56:6144–6161.
- Skalska A, Pietrzycka A, Stepniewski M. Correlation of endothelin 1 plasma levels with plasma antioxidant capacity in elderly patients treated for hypertension. Clin Biochem. 2008;42(4–5):358–364.
- Weil B, Westby C, Guilder G, et al. Enhanced endothelin-1 system activity with overweight and obesity. Am J Physiol Heart Circ Physiol. 2011;301(3):H689–H695.
- Ervin J, Schütz L, Spicer L. Current status of the role of endothelins in regulating ovarian follicular function: a review. Anim Reprod Sci. 2017;186:1–10.
- Chang Ch, Wu H, Lyu R, et al. Elevate serum levels of endothelin-1 in patients with chronic inflammatory demyelinating polyneuropathy. Clin Chim Acta. 2018;476:49–53.
- Wang Y, Tang Y, Zou Y, et al. Plasma level of big endothelin-1 predicts the prognosis in patients with hypertrophic cardiomyopathy. Int J Cardiol. 2017;243:283–289.
- Jain SK, Yadava RK, Raikar R. Role of endothelins in health and disease. J Indian Acad Clin Med. 2002;3:59–64.
- Mihaylova B, Petkova I, Rankova-Yotova CH, et al. Plasma endothelin-1 and endothelin-A receptor concentrations in patients with primary open-angle glaucoma. Biotechnol Biotechnol Equip. 2017;31(4):782–787.
- Cellini M, Strobbe E, Gizzi C, et al. Endothelin-1 plasma levels and vascular endothelial dysfunction in primary open angle glaucoma. Life Sci. 2012;91:699–702.
- Nicolela MT, Ferrier SN, Morrison ChA, et al. Effects of cold induced vasospasm in glaucoma: the role of endothelin-1. Invest Ophthalmol Vis Sci. 2003;44(6):2565–2572.
- Tezel G, Kass MA, Kolker AE, et al. Plasma and aqueous humor endothelin levels in primary open angle glaucoma. J Glaucoma. 1997;6:83–89.
- Kunimatsu S, Mayama C, Tomidokoro A, et al. Plasma endothelin-1 level in Japanese normal tension glaucoma patients. Curr Eye Res. 2006;31(9):727–731.